Early insights into the structure and function of GLP-1 were developed by Svetlana Mojsov, Joel Habener, and Dan Drucker of Massachusetts General Hospital and Jens Juul Holst of the University of Copenhagen (left to right).
GLP-1 has helped many people safely control diabetes and lose weight. Some new clinical studies have shown that they may also reduce the risk of cardiovascular disease and may even be used to help people quit smoking and drinking.